Dr Gail Carson
Head of ISARIC Global Support Centre
- Vice Chair of the Global Outbreak Alert and Response Network (GOARN)
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is a network of networks that was established in 2011 to ensure a rapid research response to outbreaks of pandemic potential. Having experienced the 2009 pandemic, SARS, and other outbreaks, many of ISARIC’s founding investigators acknowledged the need for a multidisciplinary and global approach that would encourage preparedness and collaboration in the interpandemic period.
ISARIC has, to date, gathered 43 networks from around the world – all of whom are directly involved with outbreak response and preparedness locally, regionally, and internationally. Our membership includes clinicians, clinical researchers, clinical trials professionals, virologists, microbiologists, geneticists, epidemiologists and public health professionals and statisticians – active in 130+ countries across resource settings.
In order to ensure preparedness and an efficient response, ISARIC activities have aimed to fulfil its main objectives, which are to:
- develop standardised and globally accessible research tools
- set up platforms for data collection and data sharing
- establish a primed infrastructure to epidemic responses
- enable research in resource poor settings
Since setting up, ISARIC has had the opportunity to implement these objectives in preparedness for and during outbreaks, such as for MERS-CoV, the West African Ebola outbreak, Zika and currently in response to COVID19.
Littler K. et al, (2017), Bulletin of the World Health Organization, 95, 243 - 243
Van Kerkhove MD. et al, (2016), The Lancet Global Health, 4, e911 - e912
Arabi YM. et al, (2016), Emerging Infectious Diseases, 22, 1554 - 1561
Dunning J. et al, (2016), PLOS Medicine, 13, e1001997 - e1001997
Sigfrid L. et al, (2016), ERJ Open Research, 2, 00025 - 2016
Sigfrid L. et al, (2020), BMC Medicine, 18
Norton A. et al, (2020), BMC medicine, 18
Sigfrid L. et al, (2020)
Swann OV. et al, (2020), BMJ, m3249 - m3249
Fisher DA. et al, (2020), Lancet (London, England)